Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer
ConclusionDespite extensive research and promising preclinical studies, a definite further agent in addition to fluoropyrimidines that consistently improves response rate has yet to be found.
Source: British Journal of Surgery - Category: Surgery Authors: R. Clifford,
N. Govindarajah,
J. L. Parsons,
S. Gollins,
N. P. West,
D. Vimalachandran Tags: Systematic review Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Nanotechnology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Oral Cancer | Rectal Cancers | Study | Surgery | UK Health | Xeloda